The European Regulation on Health Technology Assessment (EU HTAR) has been in effect for one year, reshaping how health technologies are assessed and accessed across Europe. But what have we learned, and what’s next?
Watch our on-demand webinar which marks this milestone and features two leading voices in the European HTA and market access space — Suzette Matthijsse, Senior Director at Lumanity and JCA Lead, bringing first-hand expertise from supporting clients on EU HTAR since 2022, and Neil Grubert, internationally recognized market access specialist, offering a global perspective on the Regulation’s implications and opportunities.
Together, they:
- Reflect on the road to HTAR launch
- Share key insights from its first year in practice
- Explore future directions for HTA and market access in Europe
Whether you’re a policymaker, market access professional, industry stakeholder, or simply passionate about the evolving European health technology landscape, this webinar will provide insights you won’t want to miss.
